opioids Archive — Page 2 of 7
-
June 3, 2021
‘Secret shopper’ study sheds light on barriers to opioid treatment for women
After a 2020 Vanderbilt University Medical Center study showed women have a difficult time accessing treatment for opioid use disorder (OUD), investigators analyzed comments received from the study’s participants to further shed light on barriers to care, which included everything from long on-hold times to difficult interactions with clinic receptionists during phone calls seeking appointments. -
April 26, 2021
Study finds increased risk of serious opioid events in mothers, regardless of dose
A new study from Vanderbilt University Medical Center researchers finds that new mothers who receive opioids after uncomplicated vaginal births face an increased risk of serious opioid-related events regardless of the opioid dosage, a finding that could significantly impact care delivery. -
February 11, 2021
Program using telehealth to treat Opioid Use Disorder
The Vanderbilt Maternal Addiction Recovery Program (VMARP) is offering virtual appointments to help reach patients in Nashville’s outlying areas for treatment of Opioid Use Disorder (OUD). -
January 12, 2021
Study shows drastic increases in opioid-affected births
The rate of mothers who had an opioid-related diagnosis when delivering their baby increased by 131% from 2010-2017, as the incidence of babies diagnosed with drug withdrawal, known as neonatal abstinence syndrome (NAS), increased by 82% nationally during that same time period. -
January 7, 2021
VA adopts enhanced recovery for total knee, total hip patients
For patients receiving total knee or total hip replacements at the Nashville VA Medical Center, the use of opioids for inpatient pain management and the total time patients spent in the hospital were both greatly reduced following the January 2016 adoption of sweeping quality improvement measures. -
November 12, 2020
Model helps predict which infants may go on to develop NAS
A new Vanderbilt-designed prediction model may make it easier to determine which infants will go on to develop neonatal abstinence syndrome (NAS), a drug withdrawal syndrome in newborns that occurs after exposure to opioids during pregnancy. -
August 24, 2020
Land of plenty (of opioids)
Surgical patients are being given more opioids than they need for postsurgical pain management, raising the risk of addiction.